Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-02

Clinical Trial Update: Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH [Phase 2]

View source ↗

Summary

Phase 2 efficacy study comparing HoLEP and TURP for lower urinary tract symptoms due to benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HoLEP
  • TURP

Snippet

Sponsor: Samsung Medical Center | Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED